内皮型NOS、内皮型NO合成酵素、内皮型一酸化窒素合成酵素、血管内皮型NO合成酵素、血管内皮型一酸化窒素合成酵素
- 関
- endothelial nitric oxide synthase、endothelial NO synthase、eNOS
WordNet
- the 14th letter of the Roman alphabet (同)n
- of or relating to or located in the endothelium
PrepTutorEJDIC
- nitrogenの化学記号
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2013/04/11 14:07:21」(JST)
[Wiki en表示]
Nitric oxide synthase 3 (endothelial cell) |
Rendering of 1M9J |
Available structures |
PDB |
Ortholog search: PDBe, RCSB |
List of PDB id codes |
1M9J, 1M9K, 1M9M, 1M9Q, 1M9R, 2LL7, 3EAH, 3NOS
|
|
|
Identifiers |
Symbols |
NOS3; ECNOS; eNOS |
External IDs |
OMIM: 163729 MGI: 97362 HomoloGene: 504 ChEMBL: 4803 GeneCards: NOS3 Gene |
EC number |
1.14.13.39 |
Gene Ontology |
Molecular function |
• actin monomer binding
• NADPH-hemoprotein reductase activity
• nitric-oxide synthase activity
• iron ion binding
• protein binding
• calmodulin binding
• FMN binding
• heme binding
• tetrahydrobiopterin binding
• arginine binding
• cadmium ion binding
• flavin adenine dinucleotide binding
• NADP binding
|
Cellular component |
• Golgi membrane
• nucleus
• nucleolus
• cytoplasm
• cytosol
• cytoskeleton
• plasma membrane
• caveola
• endocytic vesicle membrane
• apical part of cell
|
Biological process |
• angiogenesis
• ovulation from ovarian follicle
• response to hypoxia
• in utero embryonic development
• blood vessel remodeling
• regulation of sodium ion transport
• regulation of systemic arterial blood pressure by endothelin
• arginine catabolic process
• nitric oxide biosynthetic process
• mitochondrion organization
• nitric oxide mediated signal transduction
• aging
• blood coagulation
• regulation of blood pressure
• negative regulation of cell proliferation
• response to heat
• response to mechanical stimulus
• response to lead ion
• negative regulation of platelet activation
• negative regulation of muscle hyperplasia
• smooth muscle hyperplasia
• lung development
• positive regulation of guanylate cyclase activity
• lipopolysaccharide-mediated signaling pathway
• response to estradiol stimulus
• response to cytokine stimulus
• response to fluid shear stress
• response to drug
• positive regulation of apoptotic process
• negative regulation of apoptotic process
• response to amino acid stimulus
• negative regulation of potassium ion transport
• response to peptide hormone stimulus
• endothelial cell migration
• small molecule metabolic process
• response to ethanol
• positive regulation of angiogenesis
• negative regulation of blood pressure
• positive regulation of vasodilation
• nitric oxide metabolic process
• negative regulation of smooth muscle cell proliferation
• regulation of blood vessel size
• regulation of nitric-oxide synthase activity
• negative regulation of hydrolase activity
• interaction with host
• negative regulation of calcium ion transport
• response to hyperoxia
• response to lipoprotein particle stimulus
• cellular response to transforming growth factor beta stimulus
• phagosome maturation
|
Sources: Amigo / QuickGO |
|
RNA expression pattern |
|
More reference expression data |
Orthologs |
Species |
Human |
Mouse |
|
Entrez |
4846 |
18127 |
|
Ensembl |
ENSG00000164867 |
ENSMUSG00000028978 |
|
UniProt |
P29474 |
P70313 |
|
RefSeq (mRNA) |
NM_000603 |
NM_008713 |
|
RefSeq (protein) |
NP_000594 |
NP_032739 |
|
Location (UCSC) |
Chr 7:
150.69 – 150.71 Mb |
Chr 5:
24.36 – 24.38 Mb |
|
PubMed search |
[1] |
[2] |
|
|
Endothelial NOS (eNOS), also known as nitric oxide synthase 3 (NOS3) or constitutive NOS (cNOS), is an enzyme that in humans is encoded by the NOS3 gene.[1]
Endothelial NOS is a nitric oxide synthase that generates NO in blood vessels and is involved with regulating vascular tone by inhibiting smooth muscle contraction and platelet aggregation. A constitutive Ca2+ dependent NOS provides a basal release of NO. eNOS is associated with plasma membranes surrounding cells and the membranes of Golgi bodies within cells.
Contents
- 1 Clinical significance
- 2 Interactions
- 3 References
- 4 Further reading
|
Clinical significance
Variations in this gene are associated with susceptibility to coronary spasm.[2]
An association between a polymorphism in the gene and late-onset Alzheimer's disease in Chinese have been reported.[3]
Interactions
Endothelial NOS has been shown to interact with CAV1,[4] HSP90AA1[5][6][7] and GUCY1B3.[5]
References
- ^ Marsden PA, Schappert KT, Chen HS, Flowers M, Sundell CL, Wilcox JN, Lamas S, Michel T (August 1992). "Molecular cloning and characterization of human endothelial nitric oxide synthase". FEBS Lett. 307 (3): 287–93. doi:10.1016/0014-5793(92)80697-F. PMID 1379542.
- ^ Yoshimura M, Yasue H, Nakayama M, Shimasaki Y, Sumida H, Sugiyama S, Kugiyama K, Ogawa H, Ogawa Y, Saito Y, Miyamoto Y, Nakao K (July 1998). "A missense Glu298Asp variant in the endothelial nitric oxide synthase gene is associated with coronary spasm in the Japanese". Hum. Genet. 103 (1): 65–9. doi:10.1007/s004390050785. PMID 9737779.
- ^ Wang B, Tan S, Yang Z, Xie YC, Wang J, Zhou S, Li S, Zheng C, Ma X (February 2008). "Association between Alzheimer's disease and the NOS3 gene Glu298Asp polymorphism in Chinese". J. Mol. Neurosci. 34 (2): 173–6. doi:10.1007/s12031-007-9026-6. PMID 18183499.
- ^ García-Cardeña G, Fan R, Stern DF, Liu J, Sessa WC (November 1996). "Endothelial nitric oxide synthase is regulated by tyrosine phosphorylation and interacts with caveolin-1". J. Biol. Chem. 271 (44): 27237–40. doi:10.1074/jbc.271.44.27237. PMID 8910295.
- ^ a b Venema RC, Venema VJ, Ju H, Harris MB, Snead C, Jilling T, Dimitropoulou C, Maragoudakis ME, Catravas JD (August 2003). "Novel complexes of guanylate cyclase with heat shock protein 90 and nitric oxide synthase". Am. J. Physiol. Heart Circ. Physiol. 285 (2): H669–78. doi:10.1152/ajpheart.01025.2002. PMID 12676772.
- ^ Harris MB, Ju H, Venema VJ, Blackstone M, Venema RC (September 2000). "Role of heat shock protein 90 in bradykinin-stimulated endothelial nitric oxide release". Gen. Pharmacol. 35 (3): 165–70. doi:10.1016/S0306-3623(01)00104-5. PMID 11744239.
- ^ Stepp DW, Ou J, Ackerman AW, Welak S, Klick D, Pritchard KA (August 2002). "Native LDL and minimally oxidized LDL differentially regulate superoxide anion in vascular endothelium in situ". Am. J. Physiol. Heart Circ. Physiol. 283 (2): H750–9. doi:10.1152/ajpheart.00029.2002. PMID 12124224.
Further reading
- de la Monte SM, Lu BX, Sohn YK, et al. (2000). "Aberrant expression of nitric oxide synthase III in Alzheimer's disease: relevance to cerebral vasculopathy and neurodegeneration.". Neurobiol. Aging 21 (2): 309–19. doi:10.1016/S0197-4580(99)00108-6. PMID 10867216.
- Shaul PW (2002). "Regulation of endothelial nitric oxide synthase: location, location, location.". Annu. Rev. Physiol. 64: 749–74. doi:10.1146/annurev.physiol.64.081501.155952. PMID 11826287.
- Wu KK (2002). "Regulation of endothelial nitric oxide synthase activity and gene expression.". Ann. N. Y. Acad. Sci. 962: 122–30. doi:10.1111/j.1749-6632.2002.tb04062.x. PMID 12076969.
- Alp NJ, Channon KM (2005). "Regulation of endothelial nitric oxide synthase by tetrahydrobiopterin in vascular disease.". Arterioscler. Thromb. Vasc. Biol. 24 (3): 413–20. doi:10.1161/01.ATV.0000110785.96039.f6. PMID 14656731.
- Tai SC, Robb GB, Marsden PA (2005). "Endothelial nitric oxide synthase: a new paradigm for gene regulation in the injured blood vessel.". Arterioscler. Thromb. Vasc. Biol. 24 (3): 405–12. doi:10.1161/01.ATV.0000109171.50229.33. PMID 14656742.
- Kawashima S, Yokoyama M (2004). "Dysfunction of endothelial nitric oxide synthase and atherosclerosis.". Arterioscler. Thromb. Vasc. Biol. 24 (6): 998–1005. doi:10.1161/01.ATV.0000125114.88079.96. PMID 15001455.
- Duda DG, Fukumura D, Jain RK (2004). "Role of eNOS in neovascularization: NO for endothelial progenitor cells.". Trends in molecular medicine 10 (4): 143–5. doi:10.1016/j.molmed.2004.02.001. PMID 15162796.
PDB gallery
|
|
|
1d0c: BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN COMPLEXED WITH 3-BROMO-7-NITROINDAZOLE (H4B FREE)
|
|
1d0o: BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN COMPLEXED WITH 3-BROMO-7-NITROINDAZOLE (H4B PRESENT)
|
|
1d1v: BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN COMPLEXED WITH S-ETHYL-N-PHENYL-ISOTHIOUREA (H4B BOUND)
|
|
1d1w: BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN COMPLEXED WITH 2-AMINOTHIAZOLINE (H4B BOUND)
|
|
1d1x: BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN COMPLEXED WITH 1,4-PBITU (H4B BOUND)
|
|
1d1y: BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN COMPLEXED WITH 1,3-PBITU (H4B FREE)
|
|
1dm6: BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN COMPLEXED WITH N-(4-CHLOROPHENYL)-N'-HYDROXYGUANIDINE (H4B FREE)
|
|
1dm7: BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN COMPLEXED WITH HOMOARGININE (H4B FREE)
|
|
1dm8: BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN COMPLEXED WITH 1,2,4-TRIAZOLE-CARBOXAMIDINE (H4B BOUND)
|
|
1dmi: BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN COMPLEXED WITH 6S-H4B
|
|
1dmj: BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN COMPLEXED WITH 5,6-CYCLIC-TETRAHYDROPTERIDINE
|
|
1dmk: BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN COMPLEXED WITH 4-AMINO-6-PHENYL-TETRAHYDROPTERIDINE
|
|
1ed4: BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN COMPLEXED WITH IPITU (H4B FREE)
|
|
1ed5: BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN COMPLEXED WITH NNA(H4B FREE)
|
|
1ed6: BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN COMPLEXED WITH L-NIO (H4B FREE)
|
|
1foi: BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN COMPLEXED WITH 1400W(H4B-FREE)
|
|
1foj: BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN COMPLEXED WITH 7-NITROINDAZOLE-2-CARBOXAMIDINE (H4B PRESENT)
|
|
1fol: REDUCED BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN COMPLEXED WITH L-ARG(H4B-FREE)
|
|
1foo: BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN COMPLEXED WITH L-ARG AND NO(H4B-FREE)
|
|
1fop: BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN COMPLEXED WITH L-ARG AND NO(H4B-BOUND)
|
|
1i83: BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN COMPLEXED WITH N1,N14-BIS((S-METHYL)ISOTHIOUREIDO)TETRADECANE (H4B FREE)
|
|
1m9j: human endothelial nitric oxide synthase with chlorzoxazone bound
|
|
1m9k: Human Endothelial Nitric Oxide Synthase with 7-Nitroindazole Bound
|
|
1m9m: human endothelial nitric oxide synthase with 6-nitroindazole bound
|
|
1m9q: human endothelial nitric oxide synthase with 5-nitroindazole bound
|
|
1m9r: human endothelial nitric oxide synthase with 3-Bromo-7-Nitroindazole bound
|
|
1nse: BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE
|
|
1p6l: Bovine endothelial NOS heme domain with L-N(omega)-nitroarginine-2,4-L-diaminobutyric amide bound
|
|
1p6m: Bovine endothelial NOS heme domain with (4S)-N-(4-amino-5-[aminoethyl]aminopentyl)-N'-nitroguanidine bound
|
|
1p6n: Bovine endothelial NOS heme domain with L-N(omega)-nitroarginine-(4R)-amino-L-proline amide bound
|
|
1q2o: Bovine endothelial nitric oxide synthase N368D mutant heme domain dimer with L-N(omega)-nitroarginine-2,4-L-diaminobutyramide bound
|
|
1rs8: Bovine endothelial NOS heme domain with D-lysine-D-nitroarginine amide bound
|
|
1rs9: Bovine endothelial NOS heme domain with D-phenylalanine-D-nitroarginine amide bound
|
|
1zzs: Bovine eNOS N368D single mutant with L-N(omega)-Nitroarginine-(4R)-Amino-L-Proline Amide Bound
|
|
1zzt: Bovine eNOS N368D/V106M double mutant with L-N(omega)-Nitroarginine-(4R)-Amino-L-Proline Amide Bound
|
|
2g6o: Structure of bovine eNOS heme domain (BH4-free) complexed with CO
|
|
2hx2: Bovine eNOS heme domain complexed with (4S)-N-{4-Amino-5-[(2-aminoethyl)-hydroxyamino]-pentyl}-N'-nitroguanidine
|
|
2nse: BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE SUBSTRATE COMPLEX
|
|
3nos: HUMAN ENDOTHELIAL NITRIC OXIDE SYNTHASE WITH ARGININE SUBSTRATE
|
|
3nse: BOVINE ENOS, H4B-FREE, SEITU COMPLEX
|
|
4nse: BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE, H4B-FREE, L-ARG COMPLEX
|
|
5nse: BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE, H4B-FREE, HYDROXY-ARG COMPLEX
|
|
6nse: BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE, H4B-FREE, CANAVANINE COMPLEX
|
|
7nse: BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE, H4B-FREE, ADMA COMPLEX
|
|
8nse: BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE, NNA COMPLEX
|
|
9nse: BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE, ETHYL-ISOSELENOUREA COMPLEX
|
|
|
|
Oxidoreductases: dioxygenases, including steroid hydroxylases (EC 1.14)
|
|
1.14.11: 2-oxoglutarate |
- Prolyl hydroxylase
- Lysyl hydroxylase
|
|
1.14.13: NADH or NADPH |
- Flavin-containing monooxygenase
- Nitric oxide synthase
- Cholesterol 7 alpha-hydroxylase
- Methane monooxygenase
- 3A4
- Lanosterol 14 alpha-demethylase
|
|
1.14.14: reduced flavin or flavoprotein |
|
|
1.14.15: reduced iron-sulfur protein |
|
|
1.14.16: reduced pteridine (BH4 dependent) |
- Phenylalanine hydroxylase
- Tyrosine hydroxylase
- Tryptophan hydroxylase
|
|
1.14.17: reduced ascorbate |
- Dopamine beta hydroxylase
|
|
1.14.18-19: other |
- Tyrosinase
- Stearoyl-CoA desaturase-1
|
|
1.14.99 - miscellaneous |
- Cyclooxygenase
- Heme oxygenase (HMOX1)
- Squalene monooxygenase
- 17A1
- 21A2
|
|
- B
- enzm
- 1.1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 10
- 11
- 13
- 14
- 15-18
- 2.1
- 2.7.10
- 2.7.11-12
- 3.1
- 4.1
- 5.1
- 6.1-3
|
|
|
|
Metabolism: amino acid metabolism · neurotransmitter enzymes
|
|
monoamine |
histidine→histamine
|
anabolism: Histidine decarboxylase
catabolism: Histamine N-methyltransferase · Amine oxidase
|
|
tyrosine→dopamine→epinephrine
|
anabolism: Tyrosine hydroxylase · Aromatic L-amino acid decarboxylase · Dopamine beta hydroxylase · Phenylethanolamine N-methyltransferase
catabolism: Catechol-O-methyl transferase · Monoamine oxidase
|
|
glutamate→GABA
|
anabolism: Glutamate decarboxylase
catabolism: 4-aminobutyrate transaminase
|
|
tryptophan→serotonin→melatonin
|
Tryptophan hydroxylase · Aromatic L-amino acid decarboxylase · Acetylserotonin O-methyltransferase
|
|
|
arginine→NO |
Nitric oxide synthase (NOS1, NOS2, NOS3)
|
|
choline→Acetylcholine |
anabolism: Choline acetyltransferase
catabolism: Cholinesterase (Acetylcholinesterase, Butyrylcholinesterase)
|
|
|
mt, k, c/g/r/p/y/i, f/h/s/l/o/e, a/u, n, m
|
k, cgrp/y/i, f/h/s/l/o/e, au, n, m, epon
|
m (A16/C10), i (k, c/g/r/p/y/i, f/h/s/o/e, a/u, n, m)
|
|
|
|
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Cardioprotective effects of tilianin in rat myocardial ischemia-reperfusion injury.
- Guo X1, Cao W1, Yao J1, Yuan Y1, Hong Y1, Wang X1, Xing J2.
- Molecular medicine reports.Mol Med Rep.2015 Mar;11(3):2227-33. doi: 10.3892/mmr.2014.2954. Epub 2014 Nov 14.
- Tilianin, the main effective flavonoid monomer enriched from Dracocephalum moldavuca L., has been shown to have cardioprotective effects. However, the mechanism of tilianin cardioprotection remains largely unknown. The present study aimed to investigate the effects of tilianin preconditioning on my
- PMID 25405380
- Epigenetic reprogramming in atherosclerosis.
- Grimaldi V1, Vietri MT, Schiano C, Picascia A, De Pascale MR, Fiorito C, Casamassimi A, Napoli C.
- Current atherosclerosis reports.Curr Atheroscler Rep.2015 Feb;17(2):476. doi: 10.1007/s11883-014-0476-3.
- Recent data support the involvement of epigenetic alterations in the pathogenesis of atherosclerosis. The most widely investigated epigenetic mechanism is DNA methylation although also histone code changes occur during the diverse steps of atherosclerosis, such as endothelial cell proliferation, vas
- PMID 25433555
- Angiotensin II limits NO production by upregulating arginase through a p38 MAPK-ATF-2 pathway.
- Shatanawi A1, Lemtalsi T2, Yao L3, Patel C2, Caldwell RB4, Caldwell RW3.
- European journal of pharmacology.Eur J Pharmacol.2015 Jan 5;746:106-14. doi: 10.1016/j.ejphar.2014.10.042. Epub 2014 Oct 30.
- Enhanced vascular arginase activity can impair endothelium-dependent vasorelaxation by decreasing l-arginine availability to endothelial nitric oxide (NO) synthase, thereby reducing NO production and uncoupling NOS function. Elevated angiotensin II (Ang II) is a key component of endothelial dysfunct
- PMID 25446432
Japanese Journal
- Acute Modulation of Vasoconstrictor Responses by Pravastatin in Small Vessels
- GHAFFARI Nader,BALL Christine,KENNEDY Jennifer A,STAFFORD Irene,BELTRAME John F
- Circulation journal : official journal of the Japanese Circulation Society 75(6), 1506-1514, 2011-05-25
- … Background: Statins have been shown to inhibit conduit vessel constrictor responses via the endothelial nitric oxide (NO) pathway. … This effect was abolished by endothelial denudation, NO synthase (NOS) inhibition with N-ω-nitro-L-arginine methyl ester (L-NAME 300μmol/L) and Akt inhibition (Akt1/2 kinase inhibitor 500nmol/L), confirming an endothelium-dependent mechanism and implicating a NO-mediated effect via the Akt pathway. …
- NAID 10028149391
- Relationships Between Uterine Blood Flow, Peripheral Sex Steroids, Expression of Endometrial Estrogen Receptors and Nitric Oxide Synthases During the Estrous Cycle in Mares
- HONNENS Aenne,WEISSER Simone,WELTER Harald,EINSPANIER Ralf,BOLLWEIN Heinrich
- The Journal of reproduction and development 57(1), 43-48, 2011-02-01
- … The objective of this study was to investigate the relationships between uterine perfusion and estrogen, progesterone and the uterine nitric oxide synthase (NOS) system in five trotter mares during the estrous cycle. … endometrial biopsy collection for mRNA expression analysis of NOS and estrogen receptors was performed on days 0, 1, 5, 11, 15 and -3. …
- NAID 10027901025
Related Links
- NOS3 NOS3 A gene on chromosome 7q36 that encodes endothelial nitric oxide synthase (eNOS), a small molecule implicated in vascular smooth muscle relaxation through a cGMP-mediated signal transduction pathway. eNOS is a ...
- Patel JM, Martenes JR, Li YD. et al. Angiotensin IV receptor-mediated activation of lung endothelial NOS is associated with vasorelaxation. Am J Physiol Lung Cell Mol Physiol. 1998; 275:L1061–L1068. [PubMed: 9843842] 4. 59 ...
Related Pictures
★リンクテーブル★
[★]
- 英
- endothelial nitric oxide synthase、endothelial NO synthase、endothelial NOS、eNOS、endothelial isoform of nitric oxide synthase
- 関
- 内皮型NO合成酵素、内皮型NOS、血管内皮型一酸化窒素合成酵素、血管内皮型NO合成酵素、一酸化窒素合成酵素III型
[★]
内皮型一酸化窒素合成酵素、血管内皮型一酸化窒素合成酵素、内皮型NO合成酵素、血管内皮型NO合成酵素
- 関
- endothelial NO synthase、endothelial NOS、eNOS、nitric oxide synthase type III
[★]
- 英
- endothelial NO synthase、endothelial nitric oxide synthase、endothelial NOS、eNOS
- 関
- 内皮型一酸化窒素合成酵素、内皮型NOS、血管内皮型一酸化窒素合成酵素、血管内皮型NO合成酵素
[★]
- 英
- endothelial NO synthase、endothelial nitric oxide synthase、endothelial NOS
- 関
- 内皮型一酸化窒素合成酵素、内皮型NO合成酵素、内皮型NOS、血管内皮型一酸化窒素合成酵素
[★]
内皮型NO合成酵素、血管内皮型NO合成酵素、内皮型一酸化窒素合成酵素、血管内皮型一酸化窒素合成酵素
- 関
- endothelial nitric oxide synthase、endothelial NOS、eNOS
[★]
- 関
- endodermis、endothelia、endothelium
[★]
[★]
- 関
- endodermis、endothelial、endothelium
[★]
一酸化窒素合成酵素 nitric oxide synthase
[★]
一酸化窒素 nitrogen oxide nitric oxide